Edmond de Rothschild Holding’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q3 | – | Sell |
-184,060
| Closed | -$6.65M | – | 739 |
|
2023
Q2 | $6.65M | Hold |
184,060
| – | – | 0.13% | 147 |
|
2023
Q1 | $6.84M | Buy |
184,060
+15,000
| +9% | +$558K | 0.16% | 141 |
|
2022
Q4 | $7.66M | Buy |
169,060
+10,000
| +6% | +$453K | 0.18% | 130 |
|
2022
Q3 | $11.1M | Hold |
159,060
| – | – | 0.29% | 100 |
|
2022
Q2 | $10.7M | Buy |
159,060
+6,000
| +4% | +$403K | 0.26% | 115 |
|
2022
Q1 | $12.6M | Buy |
153,060
+63,060
| +70% | +$5.18M | 0.27% | 104 |
|
2021
Q4 | $13.2M | Buy |
90,000
+5,780
| +7% | +$848K | 0.29% | 99 |
|
2021
Q3 | $14.9M | Buy |
84,220
+13,960
| +20% | +$2.47M | 0.34% | 78 |
|
2021
Q2 | $11.3M | Buy |
70,260
+21,900
| +45% | +$3.54M | 0.26% | 102 |
|
2021
Q1 | $8.28M | Buy |
48,360
+7,150
| +17% | +$1.22M | 0.23% | 120 |
|
2020
Q4 | $9.05M | Sell |
41,210
-17,290
| -30% | -$3.8M | 0.3% | 98 |
|
2020
Q3 | $9.71M | Hold |
58,500
| – | – | 0.38% | 77 |
|
2020
Q2 | $6.68M | Buy |
58,500
+33,000
| +129% | +$3.77M | 0.27% | 102 |
|
2020
Q1 | $1.96M | Buy |
+25,500
| New | +$1.96M | 0.1% | 167 |
|